[Form 4] Celanese Corporation Insider Trading Activity

Rhea-AI Filing Summary

Edward G. Galante, a director of Celanese Corporation (CE), reported a sale of company common stock on 08/14/2025. The Form 4 shows 2,400 shares were disposed of at a weighted-average price of $41.272 per share, with prices in the range $40.98 to $41.45. After the reported transaction, Mr. Galante beneficially owned 21,377 shares. The filing was signed by an attorney-in-fact on 08/18/2025 and notes the seller can provide exact per-transaction quantities on request.

Positive

• None.

Negative

• Director disposed of 2,400 shares, which reduces his beneficial ownership to 21,377 shares
• Form does not state a 10b5-1 plan or reason for sale, limiting contextual information about the transaction

Insights

Financial Analyst

TL;DR: A director sold a small parcel of shares, reducing holdings to 21,377 shares; transaction appears routine.

The Form 4 documents a single non-derivative disposition of 2,400 common shares at a weighted-average price of $41.272 on 08/14/2025, with execution prices between $40.98 and $41.45. The report is signed by an attorney-in-fact. This is a straightforward disclosure of insider selling activity; the filing does not include information about the reason for sale, any related plans, or other concurrent transactions.

Corporate Governance Expert

TL;DR: Disclosure meets Section 16 reporting requirements for a director sale; no governance red flags are evident in the form.

The document identifies Edward G. Galante as a director and reports the disposal, the post-transaction beneficial ownership, and an explanation that the reported price is a weighted average across multiple trades. The form includes an attorney-in-fact signature and provides for supplemental disclosure of per-trade details upon request. There are no statements on 10b5-1 plans or other arrangements in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GALANTE EDWARD G

(Last) (First) (Middle)

C/O CELANESE CORPORATION

222 W. LAS COLINAS BLVD., SUITE 900N

(Street)

IRVING TX 75039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2025		P		2,400	A	$41.272(1)	21,377	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price in this line is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $40.98 to $41.45. The reporting person will provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price.

Remarks:

	/s/ Christine Dryden, Attorney-in-Fact for Edward G. Galante	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Edward G. Galante report on Form 4 for Celanese (CE)?

The Form 4 reports a disposition of 2,400 shares of Celanese common stock on 08/14/2025 at a weighted-average price of $41.272 per share.

How many Celanese shares does Edward G. Galante own after the reported sale?

After the reported transaction Mr. Galante beneficially owned 21,377 shares.

What price range was disclosed for the sale on the Form 4?

The filing states shares were sold in multiple transactions at prices ranging from $40.98 to $41.45 and that the reported price is a weighted average.

Who signed the Form 4 for Edward G. Galante and when?

The Form 4 was signed by Christine Dryden, Attorney-in-Fact for Edward G. Galante on 08/18/2025.

Does the Form 4 disclose a 10b5-1 trading plan for this sale?

No. The filing does not indicate that the transaction was made pursuant to a 10b5-1 plan.